RICCIARDI, SILVIA
 Distribuzione geografica
Continente #
EU - Europa 43
AS - Asia 14
NA - Nord America 13
Totale 70
Nazione #
IT - Italia 16
US - Stati Uniti d'America 12
FR - Francia 8
GB - Regno Unito 4
IL - Israele 4
IN - India 4
CN - Cina 3
NL - Olanda 3
CZ - Repubblica Ceca 2
JP - Giappone 2
RO - Romania 2
SI - Slovenia 2
AT - Austria 1
CA - Canada 1
DE - Germania 1
ES - Italia 1
FI - Finlandia 1
GR - Grecia 1
ID - Indonesia 1
RU - Federazione Russa 1
Totale 70
Città #
Paris 4
Torino 4
Chaponost 3
Amsterdam 2
Brookline 2
Cluj-Napoca 2
Genoa 2
London 2
Medvode 2
Petah Tikva 2
Tel Aviv 2
Andover 1
Ann Arbor 1
Beijing 1
Busto Arsizio 1
Cleveland 1
Edinburgh 1
Flanders 1
Hamamatsu 1
Helsinki 1
Hoorn 1
Jakarta 1
Kolkata 1
Lanzhou 1
Messina 1
Montreal 1
Mumbai 1
Nanjing 1
Pittsburgh 1
Preveza 1
Samara 1
San Diego 1
Seattle 1
Sesto San Giovanni 1
Toulouse 1
Trenton 1
Troia 1
Vienna 1
Totale 54
Nome #
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50%, file e27ce435-25e5-2581-e053-d805fe0acbaa 41
Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial, file e27ce42e-85c9-2581-e053-d805fe0acbaa 16
Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes, file e27ce431-47ef-2581-e053-d805fe0acbaa 12
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50%, file e27ce434-99bf-2581-e053-d805fe0acbaa 2
Totale 71
Categoria #
all - tutte 87
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202016 0 0 3 4 9 0 0 0 0 0 0 0
2020/202111 0 0 0 0 0 0 0 0 10 1 0 0
2021/20223 0 0 0 0 0 0 0 0 0 0 3 0
2022/202341 1 5 5 1 1 3 4 8 6 6 1 0
Totale 71